Li Su
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Oncology top 2%
- Cancer-related Molecular Pathways
Papers in
- Oncology 60
- Co-authors
- David C. ChristianiGeoffrey LiuEd HarlowLi‐Huei TsaiClaude GorkaG H EndersChia‐Ling WuMatthew Meyerson
- Journals
- International Journal of Cancer (10 papers)Journal of Clinical Oncology (7 papers)PLoS ONE (7 papers)Carcinogenesis (7 papers)Cancer Epidemiology Biomarkers & Prevention (6 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Li Su
239 papers receiving 6.2k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Cancer Research 999
- Oncology 1.5k
- Molecular Biology 2.4k
- Pathology and Forensic Medicine 618
- Health, Toxicology and Mutagenesis 460
Countries citing papers authored by Li Su
This map shows the geographic impact of Li Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Su more than expected).
Fields of papers citing papers by Li Su
This network shows the impact of papers produced by Li Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Su. The network helps show where Li Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Li Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 5 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 10 | |
| 4 | 2023 | 4 | |
| 5 | 2021 | 11 | |
| 6 | 2021 | 5 | |
| 7 | 2020 | 3 | |
| 8 | 2020 | 10 | |
| 9 | 2017 | 60 | |
| 10 | 2014 | 20 | |
| 11 | Clinic research on blood loss control by tranexamic acid during primary unilateral total knee replacement | 2013 | 2 |
| 12 | 2013 | 28 | |
| 13 | 2012 | 47 | |
| 14 | 2012 | 21 | |
| 15 | The effect of different drainage of pancreatic duct after pancreaticojejunostomy | 2011 | 1 |
| 16 | Treatment of rheumatoid arthritis with interstitial lung disease by in removal stasis. | 2010 | 2 |
| 17 | 2010 | 39 | |
| 18 | Study on the reliability, validity and norm of social support scale in Chuang peasants. | 2009 | 2 |
| 19 | 2008 | 17 | |
| 20 | Study on the Index System of Test and Assessment for Railway Passenger's Satisfaction | 2003 | 1 |
About Li Su
Li Su is a scholar working on Oncology, Cancer Research, Health, Toxicology and Mutagenesis, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 248 papers that have together received 6.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (25 papers), Esophageal Cancer Research and Treatment (16 papers), Lung Cancer Treatments and Mutations (16 papers), Epigenetics and DNA Methylation (15 papers), Cardiac Arrhythmias and Treatments (15 papers), Atrial Fibrillation Management and Outcomes (14 papers), Air Quality and Health Impacts (13 papers) and Sepsis Diagnosis and Treatment (12 papers). The work is most often cited by research in Cancer Research (999 citations), Oncology (1.5k citations), Molecular Biology (2.4k citations), Pathology and Forensic Medicine (618 citations) and Health, Toxicology and Mutagenesis (460 citations). Li Su has collaborated with scholars based in China, United States and Canada. Frequent co-authors include David C. Christiani, Geoffrey Liu, Ed Harlow, Li‐Huei Tsai, Claude Gorka, G H Enders, Chia‐Ling Wu, Matthew Meyerson, Kofi Asomaning and Rihong Zhai. Their work appears in journals such as International Journal of Cancer, Journal of Clinical Oncology, PLoS ONE, Carcinogenesis and Cancer Epidemiology Biomarkers & Prevention.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.